| http://www.w3.org/ns/prov#value | - After taking the product through Phase I, it was outlicensed to an undisclosed partner and is now in Phase II development.A third program, ALM301, is an inhibitor of Akt, a kinase that plays a key role in multiple cellular processes including apoptosis and cell proliferation
|
